DHTML Menu / JavaScript Menu Powered by Milonic
Home    |    Contact Us    |    Request Proposal     USAEU  
BASi
about
Follow BASi_news on Twitter

BASi Drug Development Services News - November 2011

Benefit from the Intelligent Alliance of Science

BASi European Operations and XenoGesis Limited, a BioCity Nottingham company, are announcing an alliance which will deliver comprehensive services in drug discovery through to clinical proof of concept. BASi is known for its expertise and personalised service in bioanalysis. XenoGesis specialises in pre-clinical DMPK and consultancy. Through our alliance we will help you navigate effectively through the discovery processes of lead optimization and candidate selection to accelerate your compounds into development.

BASi        XenoGesis

BASi Expanding its Global Reach

BASi, a leader in drug development and research instrumentation, is expanding its global business development efforts. We’ve added three representatives to our European business development team to better serve your needs.

Additions to the BASi BD Team

Justin Wildgoose of Warwickshire, UK is the business development manager for Northern Europe. He has more than 10 years experience as a study director in the area of bioanalysis, including method validation and sample analysis with LC-MS/MS. Justin comes to us from ICON of Dublin, Ireland where he most recently worked in Bioanalytical Business Development. He earned his B.Sc in Applied Chemistry at Manchester Metropolitan University.

Grace O’Maille of Norwich, England is the business development manager for general CRO services continental Europe. She has more than 15 years experience with analytical chemistry and 3 years of bioanalysis outsourcing. For the last two years, Grace used her scientific background to facilitate client relationships and develop new business in Europe for Metabolon, a global metabolite analysis service. She earned her Ph.D. in Biochemistry from Ohio State University and post-doctorate training in Mass Spectrometry at Scripps Research Institute in La Jolla, California.

Peter Dydula of the Netherlands is the business development manager for our discovery and Culex services in Continental Europe. He has about 15 years experience in sales and business development in the pharmaceutical, clinical and medical industries worldwide. Most recently, Peter was the European business development director for Gilson International BV., specializing in liquid handling and liquid chromatography. Peter has a BA from University of Western Ontario and a MBA from the University of Calgary, Alberta, Canada.

EBF 2011 4th Open Symposium

Nov 16 - 18
Barcelona, Spain
Booth B28

Drawing for new Kindle Fire
Kindle Fire

Be one of the first to own a Kindle Fire. Enter our prize drawing at our booth at EBF.
Stop by our booth to also learn how BASi can fire up your drug discovery/development program.

BASi Poster Presentations at EBF

Validation of an LC-MS/MS Method for the Determination of Tamiflu™ in Human Whole Blood Collected in the DBS Format
Peter White, Robin Lane, Bhavna Mistry

This poster demonstrates how an LC-MS/MS assay for the determination of oseltamivir and oseltamivir carboxylate was fully validated in whole blood collected in the DBS format.

The Culex® Automated In-Vivo Sampling System: A Novel Technique for Dried Blood Spot (DBS) Collection in Preclinical Species
Peter White, David Hopper, Robin Lane, Tyler DeGraw, Bhavna Mistry, Amanda Plumb and Candace Rohde

Despite the well documented benefits of DBS sampling, the manual spotting of blood samples onto DBS cards is a labour intensive process. This poster describes a novel automated technique, using the Culex® Automated in-vivo Blood Sampling System, for directly collecting whole blood samples in the DBS format.

Development of Two High Sensitivity Methods Using the AB Sciex QTRAP 5500 for the Analysis of Low Level Inhalation Compounds
Peter White, Robin Lane, Helen Upton, Julie Chiu and Sue Faulconbridge

This poster will show how the AB Sciex QTRAP 5500 coupled with optimized chromatography and sample extraction techniques combine to produce two validated methods capable of supporting the analysis of inhalation compounds.


BASi Representatives at EBF

John Maltas, General Manager, European Operations
Peter White, Director of European Laboratory Operations
Justin Wildgoose, Business Development Manager for the Northern Europe
Grace O’Maille, Business Development Manager for Continental Europe

Face-2-Face

Visit our events page and click on the corresponding F2F logo to set up a Face-2-Face meeting with a BASi representative at any of the shows or events we will be attending.

BASi on Facebook, Twitter and LinkedIN

Get up-to-the second BASi news and information from the following links:

 

For more information about items in this newsletter, or any other BASi product, call +44 (0) 24 76639574, or email us.